Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04490759 · ClinicalTrials.gov registry record
QStat Pilot Reference Range Study
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 40
- Enrollment target
NCT04490759: Completed study, sponsored by HemoSonics.
NCT04490759 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04490759 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The objective is to determine the initial reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge.
Primary Outcome
Reference range intervals determined in this study will serve as the reference range for CT on the QStat Cartridge when it is commercially available.
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-11-29 |
| Est. Completion | 2019-07-16 |
What the finished NCT04490759 record still lists
NCT04490759 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT04490759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04490759 about?
NCT04490759 is a clinical study titled "QStat Pilot Reference Range Study". The objective is to determine the initial reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge.
What is the current status of trial NCT04490759?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-11-29. Estimated completion is 2019-07-16.
What interventions are being tested in trial NCT04490759?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04490759?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI